4058 results for "*oma"
in 62.13 milliseconds.
-
Somatotropinoma Data Access Committee
Dac EGAC00001001135 -
Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
Dac EGAC00001001138 -
DAC for WGS data Romanians and Roma/Rroma (Romania)
Dac EGAC00001001184 -
Immune and Metabolic Features of Brain Metastases Melanoma (Cancer Discovery) Data Access Committee
Dac EGAC00001001216 -
Infant Glioma RNASeq Data Access Committee
Dac EGAC00001001241 -
Lymphoma Group
Dac EGAC00001001243 -
Single Cell Sequencing of Human Glioma
Dac EGAC00001001310 -
DAC for Angiosarcoma Study. National Cancer Centre Singapore.
Dac EGAC00001001311 -
Osteosarcoma Data Access Committee
Dac EGAC00001001328 -
Osteosarcoma Study HD Data Access Commitee
Dac EGAC00001001337 -
Uncovering tumor intrinsic and extrinsic factors that regulate hepatocellular carcinoma growth using patient derived xenograft assays
Dac EGAC00001001387 -
Berlin Neuroblastoma Dataset DAC
Dac EGAC00001001388 -
Data Access Commitee, UCSF Pediatric Bithalamic Glioma Genome Project
Dac EGAC00001001394 -
Exon4-mutations in KRAS in Multiple Myeloma
Dac EGAC00001001432 -
Metastatic Gliosarcoma Case Study DAC
Dac EGAC00001001434 -
Melanoma Spatial Heterogeneity Data Access Committee
Dac EGAC00001001446 -
DAC for Sex-biased patterns shaped the genetic history of Roma
Dac EGAC00001001477 -
Pediatric Low-Grade Glioma Sequencing Data Access Committee
Dac EGAC00001001498 -
Neuroblastoma Liquid biopsy data access committee
Dac EGAC00001001510 -
Roma whole genome data Data Access Commitee
Dac EGAC00001001516 -
Sahlgrenska Translational Melanoma Group
Dac EGAC00001001518 -
DAC: Whole-genome and transcriptome sequencing of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
Dac EGAC00001001533 -
Brainstem Glioma Team Data Access Committee
Dac EGAC00001001535 -
Neuroblastoma DAC
Dac EGAC00001001552 -
Accelerated single cell seeding in relapsed multiple myeloma
Dac EGAC00001001574 -
Data Access Committee - cfDNA fragmentation and personalized sequencing reveal ctDNA in urine and plasma of glioma patients
Dac EGAC00001001593 -
DAC: The genomic landscape of primary cutaneous anaplastic large cell lymphoma (pcALCL)
Dac EGAC00001001607 -
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Dac EGAC00001001625 -
MOMA - Bladder group DAC
Dac EGAC00001001642 -
INSERM U981 Team : Genomics of Non-Melanoma Skin Cancer
Dac EGAC00001001644 -
DAC for Gastric Adenocarcinoma Heterogeneity study
Dac EGAC00001001649 -
DKFZ Neuroblastoma Genomics (B087) - Data Access Committee
Dac EGAC00001001669 -
DKFZ Neuroblastoma Genomics (B087) - Data Access Committee
Dac EGAC00001001670 -
DAC Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Dac EGAC00001001675 -
MD Anderson Lymphoma & Myeloma Data Access Committee
Dac EGAC00001001685 -
DAC Whole Exome Sequences IberianRoma
Dac EGAC00001001704 -
Low-grade Serous Ovarian Carcinoma Data Access Commitee
Dac EGAC00001001763 -
Henssen Lab Neuroblastoma Circle-seq Data
Dac EGAC00001001803 -
Henssen Lab Neuroblastoma Circle-seq Data
Dac EGAC00001001804 -
DKFZ Medulloblastoma data access committee
Dac EGAC00001001844 -
DAC for Hypermutated Gliosarcoma project
Dac EGAC00001001867 -
Mantle Cell Lymphoma Michael Wang Lab
Dac EGAC00001001950 -
Neuroblastoma and cell migration DAC
Dac EGAC00001001965 -
Epigenomic heterogeneity of lung adenocarcinoma Data Access Committee
Dac EGAC00001002025 -
Retinoblastoma Data Access Committee - Institut Curie
Dac EGAC00001002050 -
Retinoblastoma Data Access Committee - Institut Curie
Dac EGAC00001002089 -
Genomic Analysis of Focal Nodular Hyperplasia with Associated Hepatocellular Carcinoma Unveils its Malignant Potential
Dac EGAC00001002123 -
Evolutionary predictability of genetic versus non genetic resistance to anticancer drugs in melanoma
Dac EGAC00001002126 -
Finland Myoma Study
Dac EGAC00001002131 -
Immune infiltrate and tumor microenvironment transcriptional programs stratify pediatric osteosarcoma into prognostic groups at diagnosis
Dac EGAC00001002133